U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
U.S. Lifts Sanctions on Brazilian Supreme Court Justice Amid Shift in Brazil Relations
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



